However, studies revealed that when circulating leptin is elevated, it contributes to the development of MASLD, and it is also linked to inflammation, angiogenesis, and fibrogenic processes that aid the progression of MASLD to MASH [89]. This evidence concerns the gene LEP and metabolic dysfunction-associated steatotic liver disease.